For research use only. Not for therapeutic Use.
Enflicoxib(Cat No.:I006394)is a selective COX-2 (cyclooxygenase-2) inhibitor used primarily for its anti-inflammatory, analgesic, and antipyretic properties. Structurally distinct from traditional NSAIDs, Enflicoxib offers targeted inhibition of COX-2 while sparing COX-1, reducing the risk of gastrointestinal side effects. It is mainly studied in veterinary medicine, particularly for managing pain and inflammation associated with osteoarthritis in dogs. Its long half-life supports sustained therapeutic effects. Enflicoxib is valuable in preclinical models investigating COX-2-mediated inflammation and joint degeneration.
CAS Number | 251442-94-1 |
Synonyms | 4-[3-(2,4-difluorophenyl)-5-(trifluoromethyl)-3,4-dihydropyrazol-2-yl]benzenesulfonamide |
Molecular Formula | C16H12F5N3O2S |
Purity | ≥95% |
IUPAC Name | 4-[3-(2,4-difluorophenyl)-5-(trifluoromethyl)-3,4-dihydropyrazol-2-yl]benzenesulfonamide |
InChI | InChI=1S/C16H12F5N3O2S/c17-9-1-6-12(13(18)7-9)14-8-15(16(19,20)21)23-24(14)10-2-4-11(5-3-10)27(22,25)26/h1-7,14H,8H2,(H2,22,25,26) |
InChIKey | ZZMJXWXXMAAPLI-UHFFFAOYSA-N |
SMILES | C1C(N(N=C1C(F)(F)F)C2=CC=C(C=C2)S(=O)(=O)N)C3=C(C=C(C=C3)F)F |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |